CLIMB BIO, INC. Increase (Decrease) in Accrued Liabilities
CLIMB BIO, INC. (CLYM) reported Increase (Decrease) in Accrued Liabilities of $2.04 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2025-05-14
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $2.04M.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-12-31 was $1.02M, a 52.84% increase year-over-year.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $95.00K.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $1.07M.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $1.45M.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$2.61M, a 714.82% decline from fiscal 2022.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $425.00K, a 86.72% decline from fiscal 2021.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $3.20M, a 231.95% increase from fiscal 2020.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $2.04M 10-Q · filed 2025-05-14 | $3.06M derived: sum of 2 quarters · filed 2025-05-14 | $3.15M derived: sum of 3 quarters · filed 2025-05-14 | $4.22M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.12M derived: sum of 2 quarters · filed 2025-03-25 | $2.19M derived: sum of 3 quarters · filed 2025-03-25 | $1.45M 10-K · filed 2025-03-25 | ||||
| 2024-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.17M derived: sum of 2 quarters · filed 2024-11-12 | $421.00K 10-Q · filed 2024-11-12 | $1.09M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $326.00K 10-Q · filed 2024-08-14 | $996.00K derived: sum of 3 quarters · filed 2025-05-14 | $505.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2024-03-31 | -$745.00K 10-Q · filed 2025-05-14 | -$75.00K derived: sum of 2 quarters · filed 2025-05-14 | -$566.00K derived: sum of 3 quarters · filed 2025-05-14 | -$1.90M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $179.00K derived: sum of 2 quarters · filed 2025-03-25 | -$1.15M derived: sum of 3 quarters · filed 2025-03-25 | -$2.61M 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | -$491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.82M derived: sum of 2 quarters · filed 2024-11-12 | -$3.28M 10-Q · filed 2024-11-12 | -$2.67M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$2.79M 10-Q · filed 2024-08-14 | -$2.18M derived: sum of 3 quarters · filed 2024-08-14 | -$3.84M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$1.46M 10-Q · filed 2024-05-15 | -$846.00K derived: sum of 2 quarters · filed 2024-05-15 | -$2.51M derived: sum of 3 quarters · filed 2024-05-15 | -$2.00M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.05M derived: sum of 2 quarters · filed 2024-03-28 | -$544.00K derived: sum of 3 quarters · filed 2024-03-28 | $425.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.16M derived: sum of 2 quarters · filed 2023-11-14 | -$188.00K 10-Q · filed 2023-11-14 | $1.22M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.47M 10-Q · filed 2023-08-10 | $1.49M 10-Q · filed 2022-08-15 | $2.88M derived: sum of 3 quarters · filed 2023-08-10 | $2.26M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $969.00K 10-Q · filed 2023-05-11 | $899.00K 10-Q · filed 2022-05-16 | $2.38M derived: sum of 2 quarters · filed 2023-05-11 | $1.76M derived: sum of 3 quarters · filed 2023-05-11 | $3.53M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $789.00K derived: sum of 2 quarters · filed 2023-03-06 | $2.56M derived: sum of 3 quarters · filed 2023-03-06 | $3.20M 10-K · filed 2023-03-06 | $3.37M 10-K · filed 2022-03-07 | |||
| 2021-09-30 | -$620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.15M derived: sum of 2 quarters · filed 2022-11-14 | $1.79M 10-Q · filed 2022-11-14 | $1.76M 10-Q · filed 2021-11-08 | $2.14M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.41M 10-Q · filed 2022-08-15 | $2.76M derived: sum of 3 quarters · filed 2022-08-15 | $2.99M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $637.00K 10-Q · filed 2022-05-16 | $990.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.22M derived: sum of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $583.00K derived: sum of 2 quarters · filed 2022-03-07 | $964.00K 10-K · filed 2022-03-07 | |||||
| 2020-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $611.00K 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | $381.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |